Protara Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Protara Therapeutics, Inc. (TARA), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are TARA insiders buying or selling?
Protara Therapeutics, Inc. insiders reported 20 open-market buys ($7.2M) and 31 sells ($4.6M) across 51 Form 4 filings — a net buying position of $2.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 1, 2026)
Insider sentiment
Net buyingNet insider flow of $2.6M in net buying.
Recent TARA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jesse Shefferman | CEO and President | Sale | 215.7K | $4.09 | $882.2K |
| Apr 9, 2026 | Jacqueline Zummo | Chief R&D Officer | Sale | 1.1K | $5.40 | $6.1K |
| Apr 2, 2026 | Jacqueline Zummo | Chief R&D Officer | Sale | 22.6K | $5.26 | $118.9K |
| May 19, 2025 | Richard S Levy | Director | Purchase | 20.0K | $3.19 | $63.8K |
| May 16, 2025 | Richard S Levy | Director | Purchase | 20.0K | $3.19 | $63.8K |
| Mar 28, 2025 | Jacqueline Zummo | Chf Scientific Operations Off | Sale | 21.2K | $4.53 | $96.1K |
| Sep 13, 2024 | Opaleye Management Inc. | 10% Owner | Sale | 158.9K | $1.71 | $271.7K |
| Sep 10, 2024 | Opaleye Management Inc. | 10% Owner | Sale | 62.0K | $1.84 | $114.3K |
| Jul 18, 2024 | Opaleye Management Inc. | 10% Owner | Sale | 11.4K | $2.44 | $27.8K |
| Jul 11, 2024 | Opaleye Management Inc. | 10% Owner | Sale | 74.6K | $2.36 | $175.8K |
| Jul 3, 2024 | Opaleye Management Inc. | 10% Owner | Sale | 8.3K | $2.12 | $17.6K |
| Jun 28, 2024 | Opaleye Management Inc. | 10% Owner | Sale | 64.6K | $2.21 | $142.5K |
| Jun 27, 2024 | Opaleye Management Inc. | 10% Owner | Sale | 12.7K | $2.26 | $28.7K |
| May 31, 2024 | Opaleye Management Inc. | 10% Owner | Sale | 15.1K | $2.92 | $44.0K |
| May 23, 2024 | Opaleye Management Inc. | 10% Owner | Sale | 42.8K | $3.05 | $130.4K |
| May 17, 2024 | Opaleye Management Inc. | 10% Owner | Sale | 70.9K | $3.25 | $230.3K |
| May 10, 2024 | Opaleye Management Inc. | 10% Owner | Sale | 182.3K | $3.11 | $567.0K |
| Dec 30, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 15.5K | $2.71 | $41.9K |
| Sep 15, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 23.9K | $3.93 | $93.8K |
| Aug 15, 2022 | Jesse Shefferman | CEO and President | Purchase | 9.1K | $3.84 | $34.8K |
| Apr 15, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 10.1K | $4.78 | $48.5K |
| Apr 8, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 10.1K | $4.78 | $48.5K |
| Mar 16, 2022 | Luke M Beshar | Director | Purchase | 10.0K | $4.25 | $42.5K |
| Mar 14, 2022 | Luke M Beshar | Director | Purchase | 10.0K | $4.46 | $44.6K |
| Jan 31, 2022 | Opaleye Management Inc. | 10% Owner | Purchase | 24.0K | $4.96 | $119.3K |
Showing the 25 most recent of 51 Form 4 filings for Protara Therapeutics, Inc..
Most active TARA insiders
- Opaleye Management Inc.24 filings
- Randall Marshall16 filings
- Jacqueline Zummo3 filings
- Jesse Shefferman2 filings
- Luke M Beshar2 filings
Ask anything about TARA insider activity
Use Trabud's AI agent to query Protara Therapeutics, Inc.'s Form 4 history in plain English — "Show me TARA CEO purchases this year" or compare it against any other ticker.
Open the AI agentTARA insider trading FAQ
Are Protara Therapeutics, Inc. insiders buying or selling?
Across 51 SEC Form 4 filings, Protara Therapeutics, Inc. (TARA) insiders reported 20 open-market purchases totaling $7.2M and 31 sales totaling $4.6M. That is a net buying position of $2.6M.
How many insiders trade TARA stock?
8 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Protara Therapeutics, Inc.. The most recent filing was accepted on Jul 1, 2026.
Where does Trabud get TARA insider trading data?
All TARA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.